Global CIS Insulin Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028
Report Code: KNJ1044548 No. of Pages: 92 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global CIS Insulin market is estimated at million US$ in 2021 and is expected to million US$ by the end of 2028, growing at a CAGR of % in the forecast period from 2022 to 2028.
This report studies the CIS Insulin market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of CIS Insulin in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Long-Acting Analog
Rapid Acting Analog
Premixed Analog
Intermediate Insulin
Short Acting Insulin
Premixed Insulin
Market Snapshot, By Application
Type I and Other Diabetes
Type II Diabetes
Main Market Players Analyzed in this report, including:
Takeda Pharmaceuticals
Sanofi Aventis
Oramed Pharmaceuticals
Novo Nordisk
Nanjing Xinbai Pharmaceutical
Merck
Eli Lilly
Boehringer Ingelheim
Biocon
The study objectives of this report are:
To study and analyze the global CIS Insulin market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of CIS Insulin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global CIS Insulin manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the CIS Insulin market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of CIS Insulin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of CIS Insulin are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 CIS Insulin Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global CIS Insulin Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and CIS Insulin
3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Type I and Other Diabetes
3.2.2 Major Buyers in Type II Diabetes
4 Market Segment: by Type
4.1 CIS Insulin Type Introduction
4.1.1 Long-Acting Analog
4.1.2 Rapid Acting Analog
4.1.3 Premixed Analog
4.1.4 Intermediate Insulin
4.1.5 Short Acting Insulin
4.1.6 Premixed Insulin
4.2 Global CIS Insulin Revenue by Type 2016-2021
5 Market Segment: by Application
5.1 CIS Insulin Type Introduction
5.1.1 Type I and Other Diabetes
5.1.2 Type II Diabetes
5.2 Global CIS Insulin Revenue by Application 2016-2021
6 Marke Segment: by Region
6.1 Global CIS Insulin Market by Region
6.2 North America CIS Insulin Market 2016-2021
6.3 Europe CIS Insulin Market 2016-2021
6.4 Asia Pacific CIS Insulin Market 2016-2021
6.5 South America CIS Insulin Market 2016-2021
6.6 Middle East and Africa CIS Insulin Market 2016-2021
7 North America
7.1 North America CIS Insulin Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe CIS Insulin Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific CIS Insulin Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America CIS Insulin Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa CIS Insulin Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Takeda Pharmaceuticals
12.1.1 Takeda Pharmaceuticals
Company Information
12.1.2 Takeda Pharmaceuticals
CIS Insulin Product Portfolio, Specification and Application
12.1.3 Takeda Pharmaceuticals
CIS Insulin Revenue and Gross Margin (2019-2021)
12.1.4 Takeda Pharmaceuticals
Key Development
12.2 Sanofi Aventis
12.2.1 Sanofi Aventis
Company Information
12.2.2 Sanofi Aventis
CIS Insulin Product Portfolio, Specification and Application
12.2.3 Sanofi Aventis
CIS Insulin Revenue and Gross Margin (2019-2021)
12.2.4 Sanofi Aventis
Key Development
12.3 Oramed Pharmaceuticals
12.3.1 Oramed Pharmaceuticals
Company Information
12.3.2 Oramed Pharmaceuticals
CIS Insulin Product Portfolio, Specification and Application
12.3.3 Oramed Pharmaceuticals
CIS Insulin Revenue and Gross Margin (2019-2021)
12.3.4 Oramed Pharmaceuticals
Key Development
12.4 Novo Nordisk
12.4.1 Novo Nordisk
Company Information
12.4.2 Novo Nordisk
CIS Insulin Product Portfolio, Specification and Application
12.4.3 Novo Nordisk
CIS Insulin Revenue and Gross Margin (2019-2021)
12.4.4 Novo Nordisk
Key Development
12.5 Nanjing Xinbai Pharmaceutical
12.5.1 Nanjing Xinbai Pharmaceutical
Company Information
12.5.2 Nanjing Xinbai Pharmaceutical
CIS Insulin Product Portfolio, Specification and Application
12.5.3 Nanjing Xinbai Pharmaceutical
CIS Insulin Revenue and Gross Margin (2019-2021)
12.5.4 Nanjing Xinbai Pharmaceutical
Key Development
12.6 Merck
12.6.1 Merck
Company Information
12.6.2 Merck
CIS Insulin Product Portfolio, Specification and Application
12.6.3 Merck
CIS Insulin Revenue and Gross Margin (2019-2021)
12.6.4 Merck
Key Development
12.7 Eli Lilly
12.7.1 Eli Lilly
Company Information
12.7.2 Eli Lilly
CIS Insulin Product Portfolio, Specification and Application
12.7.3 Eli Lilly
CIS Insulin Revenue and Gross Margin (2019-2021)
12.7.4 Merck
Key Development
12.9 Biocon
12.9.1 Biocon
Company Information
12.9.2 Biocon
CIS Insulin Product Portfolio, Specification and Application
12.9.3 Biocon
CIS Insulin Revenue and Gross Margin (2019-2021)
12.9.4 Biocon
Key Development
12.8.1 Boehringer Ingelheim
Company Information
12.8.2 Boehringer Ingelheim
CIS Insulin Product Portfolio, Specification and Application
12.8.3 Boehringer Ingelheim
CIS Insulin Revenue and Gross Margin (2019-2021)
12.8.4 Boehringer Ingelheim
Key Development
13 Global CIS Insulin Market Forecast by Region by Type and by Application
13.1 Global CIS Insulin Revenue Forecast 2022-2027
13.2 Global CIS Insulin Forecast by Regions
13.3 Global CIS Insulin Forecast by Type
13.4 Global CIS Insulin Forecast by Application
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com